Research Article
Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
Figure 1
Serum suPAR concentration was increased in patients with hepatitis B-related acute-on-chronic liver failure. The comparison of serum suPAR concentration in the health controls (HC), HBV carriers in immune tolerance (IT), chronic hepatitis B (CHB), and hepatitis B-related acute-on-chronic liver failure (HB-ACLF) groups. Values are expressed as range.